Advanced search
1 file | 328.68 KB Add to list

Early initiation of eculizumab treatment in patients with atypical haemolytic uraemic syndrome improves long-term outcomes : a pooled analysis of clinical trials

(2015) CRITICAL CARE. 19(suppl. 1). p.S116-S117
Author
Organization

Downloads

  • 8603307.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 328.68 KB

Citation

Please use this url to cite or link to this publication:

MLA
Vande Walle, Johan, et al. “Early Initiation of Eculizumab Treatment in Patients with Atypical Haemolytic Uraemic Syndrome Improves Long-Term Outcomes : A Pooled Analysis of Clinical Trials.” CRITICAL CARE, vol. 19, no. suppl. 1, 2015, pp. S116–17, doi:10.1186/cc14410.
APA
Vande Walle, J., Delmas, J., Ardissimo, G., Wang, J., Kincaid, J., & Haller, H. (2015). Early initiation of eculizumab treatment in patients with atypical haemolytic uraemic syndrome improves long-term outcomes : a pooled analysis of clinical trials. In CRITICAL CARE (Vol. 19, pp. S116–S117). Brussels, Belgium. https://doi.org/10.1186/cc14410
Chicago author-date
Vande Walle, Johan, J Delmas, G Ardissimo, J Wang, J Kincaid, and H Haller. 2015. “Early Initiation of Eculizumab Treatment in Patients with Atypical Haemolytic Uraemic Syndrome Improves Long-Term Outcomes : A Pooled Analysis of Clinical Trials.” In CRITICAL CARE, 19:S116–17. https://doi.org/10.1186/cc14410.
Chicago author-date (all authors)
Vande Walle, Johan, J Delmas, G Ardissimo, J Wang, J Kincaid, and H Haller. 2015. “Early Initiation of Eculizumab Treatment in Patients with Atypical Haemolytic Uraemic Syndrome Improves Long-Term Outcomes : A Pooled Analysis of Clinical Trials.” In CRITICAL CARE, 19:S116–S117. doi:10.1186/cc14410.
Vancouver
1.
Vande Walle J, Delmas J, Ardissimo G, Wang J, Kincaid J, Haller H. Early initiation of eculizumab treatment in patients with atypical haemolytic uraemic syndrome improves long-term outcomes : a pooled analysis of clinical trials. In: CRITICAL CARE. 2015. p. S116–7.
IEEE
[1]
J. Vande Walle, J. Delmas, G. Ardissimo, J. Wang, J. Kincaid, and H. Haller, “Early initiation of eculizumab treatment in patients with atypical haemolytic uraemic syndrome improves long-term outcomes : a pooled analysis of clinical trials,” in CRITICAL CARE, Brussels, Belgium, 2015, vol. 19, no. suppl. 1, pp. S116–S117.
@inproceedings{8603308,
  articleno    = {{P330}},
  author       = {{Vande Walle, Johan and Delmas, J and Ardissimo, G and Wang, J and Kincaid, J and Haller, H}},
  booktitle    = {{CRITICAL CARE}},
  issn         = {{1466-609X}},
  language     = {{eng}},
  location     = {{Brussels, Belgium}},
  number       = {{suppl. 1}},
  pages        = {{P330:S116--P330:S117}},
  title        = {{Early initiation of eculizumab treatment in patients with atypical haemolytic uraemic syndrome improves long-term outcomes : a pooled analysis of clinical trials}},
  url          = {{http://dx.doi.org/10.1186/cc14410}},
  volume       = {{19}},
  year         = {{2015}},
}

Altmetric
View in Altmetric